Clinical Research Facility

Scarborough, Maine 04074

Use our guide to learn which trials are right for you!

We've found
12 trials
at this facility
Ovarian Cancer Clinical Trial
Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Status: Enrolling
Updated: 10/23/2017
mi
from
Scarborough, ME
Click here to add this to my saved trials
Ovarian Neoplasms Clinical Trial
Efficacy and Safety Study of Pembrolizumab (MK-3475) in Women With Advanced Recurrent Ovarian Cancer (MK-3475-100/KEYNOTE-100)
Status: Enrolling, Phase II
Updated: 6/28/2016
mi
from
Scarborough, ME
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Scarborough, ME
Click here to add this to my saved trials
Urothelial Carcinoma Associated 1 RNA, Human Clinical Trial
Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Scarborough, ME
Click here to add this to my saved trials
Heart Failure Clinical Trial
Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Scarborough, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
mi
from
Scarborough, ME
Click here to add this to my saved trials
Head and Neck Squamous Cell Cancer Clinical Trial
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
Status: Enrolling, Phase III
Updated: 4/7/2016
mi
from
Scarborough, ME
Click here to add this to my saved trials
Advanced or Metastatic Solid Tumors Clinical Trial
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Scarborough, ME
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Scarborough, ME
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Neurology Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Scarborough, ME
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
Durvalumab vs Placebo Following Stereotactic Body Radiation Therapy in Early Stage Non-small Cell Lung Cancer Patients
Status: Upcoming, Phase III
Updated: 12/31/1969
mi
from
Scarborough, ME
Click here to add this to my saved trials
Platinum Sensitive Relapsed Ovarian Cancer Clinical Trial
Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes Mutations
Status: Upcoming, Phase III
Updated: 2/8/2016
mi
from
Scarborough, ME
Click here to add this to my saved trials